SICOR INC|4Jan 22, 9:09 PM ET

FACH WESLEY N 4

4 · SICOR INC · Filed Jan 22, 2004

Form 4

Period: 2004-01-21

VP,General Counsel & Secretary

Transactions

Sale
Common Stock
2004-01-21$27.70/sh−8,000$221,600→ 0 total
Exercise/Conversion
Common Stock
2004-01-21$9.75/sh+8,000$78,000→ 0 total
Exercise/Conversion
Common Stock
2004-01-21$15.19/sh+12,000$182,280→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−12,000→ 0 total
Exercise: $15.19Exp: 2013-03-11→ Common Stock (12,000 underlying)
Sale
Common Stock
2004-01-21$27.67/sh−12,000$332,040→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2004-01-21−8,000→ 0 total
Exercise: $9.75Exp: 2010-02-25→ Common Stock (8,000 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2004-01-21−8,000→ 0 total
Exercise: $15.75Exp: 2011-12-21→ Common Stock (8,000 underlying)

Footnotes (1)

[F1]"This option, which provided for daily vesting in equal installments over a four year period beginning on December 21, 2001, accelerated in full upon approval by stockholders of SICOR Inc. of the Agreement and Plan of Merger dated as October 31, 2003, by and among SICOR Inc., Teva Pharmaceutical Industries Limited ("Teva") and a wholly owned subsidiary of Teva."

Documents

1 file